Minnesota Attorney General Keith Ellison on Monday will share a major development in his lawsuit against three of the biggest insulin manufacturers. Ellison first accused the companies of deceptive pricing back in 2018. Now, Minnesotans are paying less for insulin — depending on where they’re buying it from.

Attorney General Keith Ellison announced a settlement with Novo Nordisk that let's Minnesotans buy its insulin products for $35 per month.

By charging upfront fees and failing to obtain proper licensing, Ellison says the companies violated Minnesota law.

ST. PAUL, Minn. – Minnesota Attorney General Keith Ellison settled with insulin manufacturers Eli Lilly, Sanofi, and Novo Nordisk, guaranteeing that Minnesotans can purchase a month’s supply of Eli Lilly and Sanofi insulin products for just $35 for the next 5 years.

Attorney General Keith Ellison reached a settlement with insulin manufacturers Eli Lilly, Sanofi, and Novo Nordisk, which guarantees that Minnesotans will be able to purchase a month’s supply of Eli L

Minnesota Attorney General Keith Ellison announced Tuesday his office is joining at least 20 other states and the city of San Francisco in lawsuits seeking to stop an executive order signed Monday by President Donald Trump that would end birthright citizenship,

Minnesota Attorney General Keith Ellison has filed a lawsuit against High Light Vapes, a Los Angeles-based e-cigarette manufacturer, charging it with marke

Novo Nordisk has agreed to a legal settlement capping insulin prices, following Minnesota's attorney general's accusations of price gouging. The settlement mandates a price cap of $35 per monthly prescription and provides free insulin to needy Minnesotans.

Minnesotans prescribed insulin won’t pay more than $35 per month for it, after the conclusion of a lawsuit against three major drug manufacturers.

The settlement resolves the Attorney General’s 2018 lawsuit alleging that Novo Nordisk deceptively priced its insulin.

The final settlement has been reached in the state's 2018 lawsuit filed against the three largest insulin manufacturers.